These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11013289)

  • 1. Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group.
    Greenberg P; Anderson J; de Witte T; Estey E; Fenaux P; Gupta P; Hamblin T; Hellstrom-Lindberg E; List A; Mufti G; Neuwirtova R; Ohyashiki K; Oscier D; Sanz G; Sanz M; Willman C
    J Clin Oncol; 2000 Oct; 18(19):3447-52. PubMed ID: 11013289
    [No Abstract]   [Full Text] [Related]  

  • 2. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
    Haferlach T; Schoch C
    Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful?
    Head DR
    Curr Opin Oncol; 2002 Jan; 14(1):19-23. PubMed ID: 11790975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytomorphology of acute myeloid leukemia and myelodysplastic syndromes].
    Kuriyama K
    Rinsho Ketsueki; 2006 Aug; 47(8):701-9. PubMed ID: 16986708
    [No Abstract]   [Full Text] [Related]  

  • 5. The new WHO nomenclature: introduction and myeloid neoplasms.
    Rodak BF; Leclair SJ
    Clin Lab Sci; 2002; 15(1):44-54. PubMed ID: 12778956
    [No Abstract]   [Full Text] [Related]  

  • 6. World Health Organization classification of the acute leukemias and myelodysplastic syndrome.
    Bennett JM
    Int J Hematol; 2000 Aug; 72(2):131-3. PubMed ID: 11039659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndromes and acute myeloid leukemia. Diagnostic criteria and pitfalls.
    Farhi DC
    Pathol Annu; 1995; 30 ( Pt 1)():29-57. PubMed ID: 7731744
    [No Abstract]   [Full Text] [Related]  

  • 8. The new World Health Organization classification of myeloid neoplasms: Q&A with James W. Vardiman, MD.
    Vardiman JW
    Clin Adv Hematol Oncol; 2003 Jan; 1(1):18, 21. PubMed ID: 16227955
    [No Abstract]   [Full Text] [Related]  

  • 9. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
    Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
    Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myelodysplastic syndromes--an overview for the practitioner].
    Solenthaler M; Tobler A
    Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
    Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
    Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a type IV blast in the FAB classification.
    Wong KF; Chan JK
    Am J Hematol; 1995 Jun; 49(2):168. PubMed ID: 7771472
    [No Abstract]   [Full Text] [Related]  

  • 14. MDS--new classification, new problem?
    Brunning RD
    Leuk Res; 2003 Jul; 27(7):567-9. PubMed ID: 12681354
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.
    Singh ZN; Huo D; Anastasi J; Smith SM; Karrison T; Le Beau MM; Larson RA; Vardiman JW
    Am J Clin Pathol; 2007 Feb; 127(2):197-205. PubMed ID: 17210514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
    Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M
    Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence re: Brunning R: Proposed WHO classification of acute myeloid leukemia and myelodysplastic syndromes. Mod Pathol 1999;1:102-4.
    Mazzella FM; Cotelingam JD; Kowal-Vern A; Shrit MA; Rector JT; Alvares C; Schumacher HR
    Mod Pathol; 2000 Jan; 13(1):101-2. PubMed ID: 10658917
    [No Abstract]   [Full Text] [Related]  

  • 18. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals.
    Cabello AI; Collado R; Ruiz MA; Martínez J; Navarro I; Ferrer R; Sosa AM; Carbonell F
    Leuk Res; 2005 Apr; 29(4):365-70. PubMed ID: 15725469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.
    Alkharabsheh O; Al-Kali A; Saadeh S; He R; Viswanatha D; Greipp P; Reichard K; Shah M; Gangat N; Patnaik M; Hogan W; Litzow M; Alkhateeb H; Nguyen PL
    Am J Hematol; 2018 Nov; 93(11):E355-E357. PubMed ID: 30074268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.